{
    "code": "02025248",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025248",
    "time": "2016-04-29 03:19:27",
    "許可證字號": "衛署藥輸字第025248號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/08\/16",
    "發證日期": "99\/08\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202524801",
    "中文品名": "安保瑞思得內服液劑 1 毫克\/毫升",
    "英文品名": "APO-RISPERIDONE SOLUTION, 1MG\/ML",
    "適應症": "思覺失調症之相關症狀、雙極性疾患之躁症發作。治療失智症病人具嚴重攻擊性，或思覺失調症類似症狀。",
    "劑型": "170內服液劑",
    "包裝": "30~4,000毫升塑膠瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RISPERIDONE",
    "限制項目": [
        "02輸入",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "6217064612  鴻汶醫藥實業有限公司",
    "申請商地址": "台中市西屯區文心路三段238號12樓",
    "主製造廠": {
        "製造廠名稱": "F070052000  APOTEX INC. - RICHMOND HILL",
        "製造廠廠址": "380 ELGIN MILLS ROAD EAST, RICHMOND HILL, ONTARIO, CANADA, L4C 5H2",
        "製造廠公司地址": "",
        "製造廠國別": "CANADA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F070025000  APOTEX INC.",
            "製造廠廠址": "150 SIGNET DRIVE,TORONTO(WESTON),ONTARIO,CANADA. M9L 1T9",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100600",
            "成分名稱": "RISPERIDONE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Apo-Risperidone Solution 仿單_依公文變更20160323 -105-03-28.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=005&Type=9"
        },
        {
            "title": "Apo-Risperidone Solution 仿單_添加賦形劑20150707-104-07-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=004&Type=9"
        },
        {
            "title": "RisperidonE os chinese leaflet 2___20120607.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=003&Type=9"
        },
        {
            "title": "Risperidone OS chinese leaflet 1___20120607.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=002&Type=9"
        },
        {
            "title": "Apo-Risperidone Solution 仿單___20101001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=001&Type=9"
        },
        {
            "title": "RISPERIDONE OS 1mg_mL - 30mL - CTN-104-07-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=007&Type=8"
        },
        {
            "title": "RISPERIDONE OS 1mg_mL - 30mL-104-07-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=006&Type=8"
        },
        {
            "title": "Risperidone OS english label___20120607.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=005&Type=8"
        },
        {
            "title": "Risperidone OS Chinese label___20120607.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=004&Type=8"
        },
        {
            "title": "Risperidone OS carton___20120607.PDF",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=003&Type=8"
        },
        {
            "title": "Apo-Risperidone成品圖片補件1___20101001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=002&Type=8"
        },
        {
            "title": "Apo-Risperidone Solution標貼___20101001.xls",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025248&Seq=001&Type=8"
        }
    ]
}